These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33574705)

  • 1. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
    Wang C; Tong J; Tang M; Lu Y; Liang G; Zhang Z; Chen T
    Cancer Manag Res; 2021; 13():1075-1085. PubMed ID: 33574705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
    Wang X; Wang Z; Lu WL; Zhao GF
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
    Zhang LX; Wei ZJ; Xu AM; Zang JH
    Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
    Fu M; Li Z; Ma J; Shen F; Zhang X
    Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
    Yu J; Huang L; Dong T; Cao L
    J Obstet Gynaecol; 2024 Dec; 44(1):2361858. PubMed ID: 38864403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Jia W; Yuan L; Ni H; Xu B; Zhao P
    Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.
    Miao C; Zhu S; Pan H; Cao X; Yuan S; Hu X
    Oncotarget; 2017 Oct; 8(50):87971-87979. PubMed ID: 29152134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Man Q; Li P; Fan J; Yang S; Xing C; Bai Y; Hu M; Wang B; Zhang K
    BMC Cancer; 2024 Apr; 24(1):464. PubMed ID: 38616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
    Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
    Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer.
    Wang W; Tong Y; Sun S; Tan Y; Shan Z; Sun F; Jiang C; Zhu Y; Zhang J
    Front Oncol; 2022; 12():936206. PubMed ID: 36110962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
    Feng JF; Huang Y; Chen QX
    World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Xie X; Luo KJ; Hu Y; Wang JY; Chen J
    Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma.
    Zhang G; Yang C; Zhao C; Xian F; Qing D; Guo Q; Song J; Liu X; Bie J
    Cancer Manag Res; 2023; 15():101-112. PubMed ID: 36743459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma.
    Zheng Z; Yang C; Cai C; Zhu H
    Cancer Manag Res; 2021; 13():7511-7516. PubMed ID: 34621132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
    He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.